• Working Hours - Mon - Thu: 8:00 - 17:00; Fri: 8:00 - 14:00
What are you looking for?

Category Archives: News And Articles

IHVN Supported Laboratory Gains International Accreditation

Picture Above: IHVN Technical Adviser Laboratory Services, Mr Abubakar Abdullahi and IHVN Senior Manager Laboratory Services, Mrs Balogun Oyebimpe receiving guests on a tour of NaLEEC at the ceremony. laboratory.

The National Laboratory Equipment Calibration Centre (NaLECC) has received international accreditation to calibrate laboratory equipment for quality assurance and optimum performance.
The center’s ISO 17025:2017 accreditation by Kenya Accreditation Service (KENAS), makes it the first in West Africa certified to provide this service.

WORLD TB DAY 2023: USAID TB-LON 3 Inaugurates School Health Club

Picture Above: United State Consular General, Will Steven and IHVN Chief Operating Officer/Managing Director, Dr Charles Olalekan Mensah at the inauguration of a school health club in Alimosho Local Government Area of Lagos State to mark World Tuberculosis Day.

To commemorate World Tuberculosis Day 2023, the USAID TB-LON 3 program has inaugurated a school health club at Orisunmbare Senior High School in Ayobo, Alimosho Local Government Area of Lagos State.

IHVN Marks World Tuberculosis Day 2023

Picture Above: A cross session of IHVN staff and stakeholders walking to create awareness on tuberculosis.

To mark the World Tuberculosis Day 2023, the Institute of Human Virology Nigeria (IHVN) has collaborated with the National Tuberculosis and Leprosy Program (NTBLCP), Stop TB Partnership and other stakeholders to raise awareness about tuberculosis and put an end to it.

Institute Screens 25,000 Women for Cervical Cancer

Picture Above: IHVN Senior Program Officer, Prevention Care and Treatment, Mrs Helen Mutong, conducting a counseling session to recruit a client for cervical cancer screening at General Hospital Karshi.

The Institute of Human Virology Nigeria (IHVN) has screened 25,175 women living with HIV for cervical cancer from 2020 to 2022 and treated more than 700 women with precancerous lesions.